Review for "Stable nebulization and muco‐trapping properties of regdanvimab/ <scp>IN</scp> ‐006 support its development as a potent, dose‐saving inhaled therapy for <scp>COVID</scp> ‐19"
crossref（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要